BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 147092)

  • 1. Immunogenetical aspects of multiple sclerosis with special regard to the HLA-histocompatibility system.
    Bertrams J
    Boll Ist Sieroter Milan; 1978 Jan; 56(6):506-15. PubMed ID: 147092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA typing on Italian multiple sclerosis population.
    Zibetti A; Cazzullo CL; Smeraldi E; Scorza-Smeraldi R
    Boll Ist Sieroter Milan; 1978 Jan; 56(6):539-43. PubMed ID: 147093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of histocompatibility haplotype HLA-A3-B7 with multiple sclerosis.
    Bertrams HJ; Kuwert EK
    J Immunol; 1976 Nov; 117(5 Pt.2):1906-12. PubMed ID: 993587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple sclerosis immunogenetics: a) associations between HL-A antigens and high measles antibody levels. b) existence of common MLR/immune response determinants in MS patients.
    Cazzullo CL; Smeraldi E
    Boll Ist Sieroter Milan; 1974; 53(5):615-24. PubMed ID: 4282585
    [No Abstract]   [Full Text] [Related]  

  • 5. [Histocompatibility antigens in multiple sclerosis patients].
    Khondkarian OA; Tananov AT; Zavalishin IA; Nevskaia OM; Kut'ina RM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(2):7-10. PubMed ID: 7234266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity.
    Wiendl H; Feger U; Mittelbronn M; Jack C; Schreiner B; Stadelmann C; Antel J; Brueck W; Meyermann R; Bar-Or A; Kieseier BC; Weller M
    Brain; 2005 Nov; 128(Pt 11):2689-704. PubMed ID: 16123145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Multiple sclerosis and the histocompatibility system].
    Khondkarian OA; Tananov AT; Zavalishin IA; Nevskaia OM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(2):167-71. PubMed ID: 6176089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced expression of peptide-loaded HLA class I molecules on multiple sclerosis lymphocytes.
    Li F; Linan MJ; Stein MC; Faustman DL
    Ann Neurol; 1995 Aug; 38(2):147-54. PubMed ID: 7654061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple sclerosis in 3 gipsy and 2 partly gipsy subjects (a clinical and immunogenetic study).
    Pálffy G; Gyódi E; Petrányi G
    Acta Med Hung; 1986; 43(1):31-7. PubMed ID: 3774417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-D typing with an association of Dw2 and absent immune responses towards herpes simplex (type i) antigen in multiple sclerosis.
    Paty DW; Cousin HK; Stiller CR; Boucher DW; Furesz J; Warren KG; Marchuk L; Dossetor JB
    Transplant Proc; 1977 Dec; 9(4):1845-8. PubMed ID: 203060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histocompatibility (HLA) antigens and multiple sclerosis in Israelis.
    Brautbar C; Amar A; Cohen I; Kahana E; Cohen T; Bloch D; Grosse-Wilde H; Alter M
    Isr J Med Sci; 1982 May; 18(5):631-4. PubMed ID: 7096048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myelin basic protein-specific T-cell responses in identical twins discordant or concordant for multiple sclerosis.
    Martin R; Voskuhl R; Flerlage M; McFarlin DE; McFarland HF
    Ann Neurol; 1993 Oct; 34(4):524-35. PubMed ID: 7692808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mixed lymphocyte culture determinants, measles infection and multiple sclerosis.
    Platz P; Dupont B; Fog T; Ryder L; Thomsen M; Svejgaard A; Jersild C
    Proc R Soc Med; 1974 Nov; 67(11):1133-6. PubMed ID: 4140520
    [No Abstract]   [Full Text] [Related]  

  • 14. Association of HLA and multiple sclerosis.
    Martin R; Vogt AB; Kropshofer H; Lichtenfels R
    Behring Inst Mitt; 1994 Jul; (94):158-70. PubMed ID: 7998908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA antigens and mitogen responsiveness in multiple sclerosis.
    Paty DW; Cousin HK; Stiller CR
    Transplant Proc; 1977 Mar; 9(1 Suppl 1):187-9. PubMed ID: 300927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA antigens in multiple sclerosis in Alsace.
    Rumbach L; Tongio MM; Warter JM; Marescaux C; Grange D; Mayer S; Collard M
    Biomed Pharmacother; 1985; 39(7):385-9. PubMed ID: 3830266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined influences of Gm and HLA phenotypes upon multiple sclerosis susceptibility and severity.
    Salier JP; Sesboüé R; Martin-Mondière C; Daveau M; Cesaro P; Cavelier B; Coquerel A; Legrand L; Goust JM; Degos JD
    J Clin Invest; 1986 Aug; 78(2):533-8. PubMed ID: 3461005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of unrelated HLA-identical bone marrow donors: RFLP, oligotyping and PCR fingerprinting for HLA class II compared to MLC responses.
    Mazzola G; el-Borai MH; Berrino M; Cornaglia M; Amoroso A
    Bone Marrow Transplant; 1993; 11 Suppl 1():24-7. PubMed ID: 8095414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA antigen segregation analysis in multiple sclerosis (MS) families.
    Bertrams J; Kuwert E
    Z Immunitatsforsch Immunobiol; 1976 Nov; 152(3):200-8. PubMed ID: 1007375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The HLA system and multiple sclerosis.
    Zanussi C; Scorza-Smeraldi R
    Boll Ist Sieroter Milan; 1978 Jan; 56(6):531-8. PubMed ID: 75733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.